The pet diabetes care devices market is capturing a valuation of US$ 2.3 billion in 2023 and is expected to reach US$ 4.3 billion by 2033. The market is registering a CAGR of 6.2% during the forecast period.
The market is influenced by the rising pet population and increasing prevalence of diabetes among pets. The several factors that drive the global market are:
These factors are anticipated to boost the market share in the coming years.
Stringent Regulations and Limit Awareness Decline the Market Growth
The market has several restraining factors that may limit market growth are:
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 6.2% |
| Market Valuation (2023) | US$ 2.3 billion |
| Market Valuation (2033) | US$ 4.3 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market was valued at US$ 1.7 billion in 2018 and US$ 2.20 billion in 2022. The market secured a CAGR of 5.7% between 2018 and 2022. The market has grown moderately during this period through collaboration and product launches.
The market expanded through various factors such as pet illness, growing pet population, lack of proper meals, and lack of awareness. These essential factors increased the adoption of pet diabetes care devices. The increasing pet healthcare infrastructure and innovation on pet care devices sustain market growth.
Based on animal type, the dog category dominate the global market by securing a share of 48.0% during the forecast period. Dogs are commonly affected by diabetes, which uplifts the demand for pet diabetes care devices. Pet diabetes care devices are beneficial for managing pets' blood glucose and monitoring their health. A few of these devices are insulin pens and syringes.
Other animals, such as cats, rabbits, and horses, are also diagnosed with diabetes that require the same pet care devices. Overall, dogs are highly diagnosed with diabetes and are estimated to lead the global market by 2033. These devices determine accurate results related animal's age, glucose level, weight, and related health conditions.
Based on the device, insulin syringes are leading the global market by registering a share of 32.1% by 2033. Insulin syringes are highly adopted devices to treat pet diabetes around the globe. These insulin syringes are designed in various sizes and shapes to be easily used and deliver insulin doses to pets. The insulin syringes are made of plastic and glass, which are more comfortable and provide better experiences.
Insulin syringes are highly preferred over other devices, such as pumps and insulin pens, due to their lower maintenance cost. These insulin syringes are widely used for vaccinations, blood tests, and administering medications. It includes catheter syringes, safety syringes, and among others.
The demand for insulin syringes is increasing due to its aging demographics, growing population, and prevalence of diabetes and other chronic diseases. These factors play a key role in upsurging the adoption of insulin syringes.
Principal Consultant
The United States is leading the global market by capturing a share of 27% by 2033. The United States is rapidly growing by increasing pet owners, raising pet health awareness, and government initiatives. Pet owners are increasingly adopting pet diabetes care devices such as monitoring systems, syringes, and insulin pens for treating pets.
The United States pet diabetes care devices market includes key players such as Vetoquinol S.A., Zoetic Inc, IDEXX Laboratories Inc, and Merck & Co. Inc. These companies are developing and innovating technologically advanced products to satisfy end-users' demand. The United States market is estimated to expand due to increasing awareness and growing key players.
The United Kingdom is one of the significant countries that secured a CAGR of 6.30% during the forecast period. The market is growing due to the rising pet population, the prevalence of chronic diseases, and the increasing pet population. These owners are focused to monitor their pet's wellness and are increasing the adoption of pet diabetes.
Key players in the United Kingdom pet diabetes care devices market include Vetsulin, Abbott Laboratories, Medtronic, Novo Nordisk, and Zoetis Inc. These companies are implementing pet care devices with advanced technologies. The United Kingdom has well-established veterinary sectors, such as clinics and hospitals for pet care, specialized professions, and doctors. These healthcare sectors are rising in demand for pet diabetes care devices, significantly fueling the United Kingdom market.
China is registering a CAGR of 8.20% in the global market. Several factor influence China's pet diabetes care devices market are:
These crucial factors upsurge China market to another height.
India is one of the prominent leaders in the Asia Pacific that may secure a CAGR of 7.50% by 2033. India is rapidly growing by rising pet ownership and the growing pet population. Pet care devices are used to treat and monitor pets' healthcare conditions. The increasing disposable income, changing living styles, growing trends, and modernization fuel the Indian pet diabetes care devices market.
The essential players in the country are Dickinson and Company, Zoetis Inc, Novo Nordisk A/S, and Merck & Co. Inc. These players are expanding the market by innovating products with advanced technologies, distribution channels, and collaborations in the country.
The manufacturers are bringing lucrative opportunities in the market by innovating pet care products through various strategic methods. These strategies are as follows:
Manufacturers implement these strategies to provide better healthcare and management for their pet's diabetes.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is highly competitive and presents several key players. These players are investing in research and development activities to develop new marketing strategies to develop better, affordable, unique pet care devices. The key players are adopting several marketing methodologies. Including mergers, acquisitions, product launches, collaborations, and partnerships.
Other Essential Players in the Global Market are:
Recent Developments in the Global Market are:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered |
|
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market will rise at a 6.2% CAGR through 2033.
By 2033, the market will reach US$ 2.3 billion.
Growing population of pets with diabetes propels market growth.
The 2023 market value is US$ 2.3 billion.
By 2033, the market will reach US$ 4.3 billion.
1. Executive Summary | Pet Diabetes Care Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033
5.3.1. Cats
5.3.2. Dogs
5.3.3. Horses
5.4. Y-o-Y Growth Trend Analysis By Animal Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Device, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Device, 2023 to 2033
6.3.1. Insulin Delivery Devices
6.3.2. Insulin Delivery Pens
6.3.3. Insulin Syringes
6.3.4. Glucose Monitoring Devices
6.4. Y-o-Y Growth Trend Analysis By Device, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Device, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Veterinary Clinics
7.3.2. Home Care Settings
7.3.3. Veterinary Hospitals
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. Middle East and Africa(MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Animal Type
9.2.3. By Device
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Animal Type
9.3.3. By Device
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Animal Type
10.2.3. By Device
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Animal Type
10.3.3. By Device
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Animal Type
11.2.3. By Device
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Animal Type
11.3.3. By Device
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Animal Type
12.2.3. By Device
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Animal Type
12.3.3. By Device
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Animal Type
13.2.3. By Device
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Animal Type
13.3.3. By Device
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Animal Type
14.2.3. By Device
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Animal Type
14.3.3. By Device
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of Middle East and Africa(MEA)
15.2.2. By Animal Type
15.2.3. By Device
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Animal Type
15.3.3. By Device
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. The USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Animal Type
16.1.2.2. By Device
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Animal Type
16.2.2.2. By Device
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Animal Type
16.3.2.2. By Device
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Animal Type
16.4.2.2. By Device
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Animal Type
16.5.2.2. By Device
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Animal Type
16.6.2.2. By Device
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Animal Type
16.7.2.2. By Device
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Animal Type
16.8.2.2. By Device
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Animal Type
16.9.2.2. By Device
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Animal Type
16.10.2.2. By Device
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Animal Type
16.11.2.2. By Device
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Animal Type
16.12.2.2. By Device
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Animal Type
16.13.2.2. By Device
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Animal Type
16.14.2.2. By Device
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Animal Type
16.15.2.2. By Device
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Animal Type
16.16.2.2. By Device
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Animal Type
16.17.2.2. By Device
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Animal Type
16.18.2.2. By Device
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Animal Type
16.19.2.2. By Device
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Animal Type
16.20.2.2. By Device
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Animal Type
16.21.2.2. By Device
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Animal Type
17.3.3. By Device
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Allison Medical
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Apotex Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Becton, Dickinson and Company
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Boehringer Ingelheim Vetmedica Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Henry Schein Animal Health
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Med Trust LLC
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Merck & Co., Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. UltiMed Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Zoetis Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. ALR Technologies Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Pet Diabetes Care Devices Market
